Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients

Kidney International

Volumn 87, Issue 2, 2015, Pages 434-441

  Dahlmann, Anke ^a,b   Dörfelt, Kathrin ^a   Eicher, Florian ^a   Linz, Peter ^a   Kopp, Christoph ^a,b   Mössinger, Irina ^a   Horn, Stephan ^c   Büschges Seraphin, Beatrix ^d   Wabel, Peter ^e   Hammon, Matthias ^b   Cavallaro, Alexander ^b   Eckardt, Kai Uwe ^b   Kotanko, Peter ^f   Levin, Nathan W ^f   Johannes, Bernd ^g   Uder, Michael ^b   Luft, Friedrich C ^h,i   Müller, Dominik N ^h   Titze, Jens M ^a,i  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Kuratorium für Heimdialyse und Nierentransplantation e V   (Germany)

^d Kuratorium für Heimdialyse und Nierentransplantation e V   (Germany)

^e FRESENIUS MEDICAL CARE   (Germany)

^f RENAL RESEARCH INSTITUTE   (United States)

^g GERMAN AEROSPACE CENTER DLR   (Germany)

^h MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease; hemodialysis; ultrafiltration

Indexed keywords

POTASSIUM ION; SODIUM 23; SODIUM ION; VASCULOTROPIN C; HEMODIALYSIS FLUID; SODIUM;

ADULT; AGE; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; MUSCLE LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA OSMOLALITY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SKIN; SODIUM METABOLISM; ULTRAFILTRATION; BLOOD; CASE CONTROL STUDY; HEMODIALYSIS; ISOLATION AND PURIFICATION; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; TISSUE DISTRIBUTION;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL DIALYSIS; SODIUM; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84922251902     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.269     Document Type: Article

References (45)

1. Guyton AC, Coleman TC, Cowley AW Jr et al. A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res 1974; 35: 159-176.
2. Levin NW, Kotanko P, Eckardt KU et al. Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference. Kidney Int 2010; 77: 273-284.
3. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500-507.
4. Al-Hilali N, Al-Humoud H, Ninan VT et al. Blood pressure control in haemodialysis patients: an audit. Nephrology 2006; 11: 100-104.
5. Davenport A. Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract 2006; 104: c120-c125.
6. Krautzig S, Janssen U, Koch KM et al. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553.
7. Chazot C. Can chronic volume overload be recognized and prevented in hemodialysis patients? Use of a restricted-salt diet. Semin Dial 2009; 22: 482-486.
8. Hur E, Usta M, Toz H et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 2013; 61: 957-965.
9. Kayikcioglu M, Tumuklu M, Ozkahya M et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956-962.
10. Mc Causland FR, Waikar SS, Brunelli SM. Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int 2012; 82: 204-211.
11. Foley RN, Herzog CA, Collins AJ et al. Blood pressure and long-Term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 2002; 62: 1784-1790.
12. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965-2971.
13. Heerspink HL, Ritz E. Sodium chloride intake: is lower always better? J Am Soc Nephrol 2012; 23: 1136-1139.
14. Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 2013; 83: 377-383.
15. Titze J, Bauer K, Schafflhuber M et al. Internal sodium balance in DOCAsalt rats: a body composition study. Am J Physiol Renal Physiol 2005; 289: F793-F802.
16. Titze J, Lang R, Ilies C et al. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol 2003; 285: F1108-F1117.
17. Ziomber A, Machnik A, Dahlmann A et al. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-Treated rats. Am J Physiol Renal Physiol 2008; 295: F1752-F1763.
18. Machnik A, Dahlmann A, Kopp C et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces saltsensitive hypertension in rats. Hypertension 2010; 55: 755-761.
19. Machnik A, Neuhofer W, Jantsch J et al. Macrophages regulate saltdependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15: 545-552.
20. Wiig H, Schroder A, Neuhofer W et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 2013; 123: 2803-2815.
21. Kopp C, Linz P, Dahlmann A et al. 23Na magnetic resonance imagingdetermined tissue sodium in healthy subjects and hypertensive patients. Hypertension 2013; 61: 635-640.
22. Kopp C, Linz P, Wachsmuth L et al. (23)Na magnetic resonance imaging of tissue sodium. Hypertension 2012; 59: 167-172.
23. Kopp C, Linz P, Hammon M et al. Seeing the sodium in a patient with hypernatremia. Kidney Int 2012; 82: 1343-1344.
24. Titze J, Dahlmann A, Lerchl K et al. Spooky sodium balance. Kidney Int 2013; 85: 759-767.
25. Dhondt AW, Vanholder RC, De Smet RV et al. Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int 2003; 63: 1540-1547.
26. Titze J, Shakibaei M, Schafflhuber M et al. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol 2004; 287: H203-H208.
27. Schafflhuber M, Volpi N, Dahlmann A et al. Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats. Am J Physiol Renal Physiol 2007; 292: F1490-F1500.
28. Helle F, Karlsen TV, Tenstad O et al. High-salt diet increases hormonal sensitivity in skin pre-capillary resistance vessels. Acta Physiol (Oxf) 2013; 207: 577-581.
29. Kleinewietfeld M, Manzel A, Titze J et al. Sodium chloride drives autoimmune disease by the induction of pathogenic T17 cells. Nature 2013; 496: 518-522.
30. Ivanova LN, Archibasova VK, Shterental I. [Sodium-depositing function of the skin in white rats]. Fiziol Zh SSSR Im I M Sechenova 1978; 64: 358-363.
31. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2012; 75: 685-363.
32. Cavanagh MM, Weyand CM, Goronzy JJ. Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol 2012; 24: 488-493.
33. Chertow GM, Johansen KL, Lew N et al. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 2000; 57: 1176-1181.
34. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398.
35. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911.
36. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
37. Lely AT, Salahuddin S, Holwerda KM et al. Circulating lymphangiogenic factors in preeclampsia. Hypertens Pregnancy 2013; 32: 42-49.
38. Pitts RF. Volume and Composition of the Body Fluids. Year Book: Chicago, IL, USA, 1974.
39. Bergstrom WH. The participation of bone in total body sodium metabolism in the rat. J Clin Invest 1955; 34: 997-1004.
40. Edelman IS, Leibman J. Anatomy of body water and electrolytes. Am J Med 1959; 27: 256-277.
41. Farber SJ. Mucopolysaccharides and sodium metabolism. Circulation 1960; 21: 941-947.
42. Farber SJ, Schubert M, Schuster N. The binding of cations by chondroitin sulfate. J Clin Invest 1957; 36: 1715-1722.
43. Edelman IS, Leibman J, O'Meara MP et al. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37: 1236-1256.
44. Stewart IJ, Henrich WL. Is there any role for sodium modeling in the prevention of intradialytic hypotension in patients with large interdialytic fluid gains? Semin Dial 2011; 24: 422-423.
45. Schwenger V, Weigand MA, Hoffmann O et al. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury-A randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 2012; 16: R140.